**BREAKING NEWS | STATE CAPITOL, AUSTIN, TX**
**DATELINE: [CURRENT DATE]**
**WHO:** Texas Attorney General Ken Paxton
**WHAT:** Announces formal investigation into pharmaceutical pricing practices, alleging collusion and price-fixing among several major drug manufacturers.
**WHERE:** Texas State Capitol, Austin; investigation targets national pharmaceutical companies with significant operations in the state.
**WHEN:** Press conference held at 10:00 AM Central Time today.
**WHY:** Based on a 14-month inquiry by the Consumer Protection Division, evidence suggests a coordinated effort to artificially inflate prices for life-saving medications, including insulin and epinephrine auto-injectors, impacting over 4.5 million Texas patients.
**HOW:** The Attorney General’s Office will issue civil investigative demands, effectively subpoenas, to obtain internal communications and pricing data. Paxton stated the investigation seeks to recover "billions of dollars in taxpayer-funded healthcare costs" and impose financial penalties under the Texas Deceptive Trade Practices Act.
**ADDITIONAL CONTEXT:** This probe follows a series of similar multistate lawsuits led by Attorney General Paxton against opioid manufacturers and Google, signaling a continued aggressive posture toward corporate consolidation and pricing power. A preliminary report is expected within 90 days.